Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Receivables (2016 - 2025)

Alkermes (ALKS) has disclosed Receivables for 15 consecutive years, with $334.0 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 14.25% to $334.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $334.0 million through Dec 2025, down 14.25% year-over-year, with the annual reading at $334.0 million for FY2025, 14.25% down from the prior year.
  • Receivables for Q4 2025 was $334.0 million at Alkermes, down from $355.1 million in the prior quarter.
  • The five-year high for Receivables was $389.5 million in Q4 2024, with the low at $257.8 million in Q1 2021.
  • Average Receivables over 5 years is $319.5 million, with a median of $324.2 million recorded in 2021.
  • The sharpest move saw Receivables decreased 15.69% in 2022, then rose 27.5% in 2023.
  • Over 5 years, Receivables stood at $326.6 million in 2021, then dropped by 9.08% to $296.9 million in 2022, then grew by 12.22% to $333.2 million in 2023, then rose by 16.91% to $389.5 million in 2024, then fell by 14.25% to $334.0 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $334.0 million, $355.1 million, and $356.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.